Additionally, the suppression of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-α) causes NAFLD by decreasing the FA β-oxidation in hepatocytes [2]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.